Cargando…
Global Deletion of 11β-HSD1 Prevents Muscle Wasting Associated with Glucocorticoid Therapy in Polyarthritis
Glucocorticoids provide indispensable anti-inflammatory therapies. However, metabolic adverse effects including muscle wasting restrict their use. The enzyme 11beta-hydroxysteroid dehydrogenase type 1 (11β-HSD1) modulates peripheral glucocorticoid responses through pre-receptor metabolism. This stud...
Autores principales: | Webster, Justine M., Sagmeister, Michael S., Fenton, Chloe G., Seabright, Alex P., Lai, Yu-Chiang, Jones, Simon W., Filer, Andrew, Cooper, Mark S., Lavery, Gareth G., Raza, Karim, Langen, Ramon, Hardy, Rowan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8346140/ https://www.ncbi.nlm.nih.gov/pubmed/34360594 http://dx.doi.org/10.3390/ijms22157828 |
Ejemplares similares
-
OR09-3 11β-HSD1 Mediates a Partial Suppression of Muscle Atrophy in Chronic Inflammatory Disease in Response to Therapeutic Glucocorticoids
por: Webster, Justine, et al.
Publicado: (2019) -
Therapeutic glucocorticoids prevent bone loss but drive muscle wasting when administered in chronic polyarthritis
por: Fenton, C. G., et al.
Publicado: (2019) -
SAT-003 Therapeutic Glucocorticoids Prevent Local and Systemic Bone Loss but Exacerbate Muscle Wasting When Administered in Chronic Inflammation
por: Fenton, Chloe, et al.
Publicado: (2019) -
Exploring the Interface between Inflammatory and Therapeutic Glucocorticoid Induced Bone and Muscle Loss
por: Webster, Justine M., et al.
Publicado: (2019) -
SAT276 Glucocorticoid Excess Elevates Metabolic Rate Via A 11b-HSD1 Dependent Mechanism In C57BL/6J Mice
por: Heaselgrave, Samuel, et al.
Publicado: (2023)